We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with uncontrolled gout had additional burdens ...
Please provide your email address to receive an email when new articles are posted on . Patients with gout were more likely than other patients to receive chronic opioids. Female sex, underweight BMI, ...
Patients with gout are more likely than those without to initiate chronic opioid use. Patients with gout are more likely than those without to initiate chronic opioid use, according to study results ...
Researchers assessed the criteria for gout remission and defined the criteria for a complete response in patients with chronic refractory gout. Results from a post hoc analysis published in ACR Open ...
Gout was associated with a 30% higher risk for chronic opioid exposure based on US Veteran's Health Administration data. Patients with gout in the United States are at greater risk for chronic opioid ...
BLOOM (TAMPA) – Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness show Bloom, to discuss the often-overlooked connection ...
Veterans with gout were 30% more likely to be prescribed chronic opioid therapy than those without gout, with factors such as female sex, underweight BMI, current smoking status, and a higher burden ...
JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...
This week's topics include the impact of lipoprotein (a), or Lp (a), frailty as a predictor of dementia, a diabetes medicine in kidney stones and gout, and the impact of multiple chronic medical ...
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...
Credit: Getty Images. The DISSOLVE I and II trials evaluated the efficacy and safety of 2 different dose levels of SEL-212 in adults 19 years of age and older with chronic refractory gout. Treatment ...
You might have gout, a type of arthritis that afflicts more than nine million Americans. 1 There are oral treatments available, but a much smaller group of people still experience continued symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results